Status:
UNKNOWN
SMARTHEART Validation Study
Lead Sponsor:
University of Leicester
Conditions:
Cardiovascular Diseases
Eligibility:
All Genders
18+ years
Brief Summary
To compare the accuracy of novel smartphone or wearable ECG devices to a gold standard ECG in patients with normal and abnormal ECGs.
Detailed Description
Assess the effect of the following on the accuracy of the recorded ECG compared to a gold standard ECG: * Posture or position of the patient * Movement * Amount of hair on the ECG site * Skin conditi...
Eligibility Criteria
Inclusion
- Participant is willing and able to give informed consent for participation in the study.
- Must have an adequate understanding of written and spoken English
- Able (in the Investigators opinion) and willing to comply with study requirements.
- Must be over 18 years of age
- Must be deemed clinically stable by their direct care team.
Exclusion
- Subjects who do not have an adequate understanding of written and spoken English
- Patients who are medically unstable, as defined by the patient's direct care team.
- Patients who are unable to give informed consent
- Patients who are deemed clinically unstable by their direct care team
Key Trial Info
Start Date :
July 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2022
Estimated Enrollment :
128 Patients enrolled
Trial Details
Trial ID
NCT04755582
Start Date
July 1 2021
End Date
December 31 2022
Last Update
February 16 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Glenfield Hospital, University Hospitals of Leicester NHS Trust
Leicester, Leicestershire, United Kingdom, LE3 9QP